← Open Payments lookup

JEREMY WINELL: Open Payments

NPI 1598822736 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$730 in 34 payments from 15 companies in 2025. Trend: 2023 $367 · 2024 $699 · 2025 $730

Food & beverage: $730
CompanyPaymentsAmount
Takeda Pharmaceuticals U.S.A., Inc.9$144
Agios Pharmaceuticals, Inc.3$87
Janssen Biotech, Inc.3$85
Merck Sharp & Dohme LLC4$85
Daiichi Sankyo Inc.2$48
Novartis Pharmaceuticals Corporation2$45
SERVIER PHARMACEUTICALS LLC2$39
Syndax Pharmaceuticals, Inc.2$33
Nuvation Bio Inc.1$31
Genmab U.S., Inc.1$28

Products named: PYRUKYND, KEYTRUDA, TECVAYLI, NINLARO, Enhertu, Fabhalta, Tibsovo, VPRIV.

Industry payments across NY — which companies pay providers there.